Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003

Int J Antimicrob Agents. 2005 Jun;25(6):539-41. doi: 10.1016/j.ijantimicag.2004.10.017.

Abstract

Susceptibility to moxifloxacin, penicillin and erythromycin was determined for 592 invasive Streptococcus pneumoniae collected from 20 English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) during 2003. Resistance to moxifloxacin, penicillin and erythromycin was observed in 0.8%, 5.4% and 13% of the isolates, respectively. These results show that the large majority of pneumococci were susceptible to moxifloxacin in 2003, the year when it was licensed for clinical use in the UK.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Aza Compounds / pharmacology*
  • Drug Resistance, Bacterial
  • England
  • Erythromycin / pharmacology
  • Fluoroquinolones
  • Humans
  • Inpatients
  • Microbial Sensitivity Tests
  • Moxifloxacin
  • Penicillins / pharmacology
  • Quinolines / pharmacology*
  • Streptococcus pneumoniae / drug effects*
  • Streptococcus pneumoniae / isolation & purification

Substances

  • Anti-Bacterial Agents
  • Aza Compounds
  • Fluoroquinolones
  • Penicillins
  • Quinolines
  • Erythromycin
  • Moxifloxacin